Bayer AG News Headlines

BAYRY 
$135.571
*  
1.751
1.31%
Get BAYRY Alerts
*Delayed - data as of Aug. 26, 2014  -  Find a broker to begin trading BAYRY now


Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
8/26/2014 3:31:00 PM - Investopedia

Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
8/22/2014 5:55:00 PM - Zacks.com

EUROPE MARKETS: Maersk Lifts Stoxx 600 With 4.9% Leap
8/19/2014 12:01:00 PM - Dow Jones Business News

Boston Scientific Poised on Core Market Stabilization - Analyst Blog
8/14/2014 2:50:00 PM - Zacks.com

Regeneron's Eye Drug Eylea Cleared in the EU for DME - Analyst Blog
8/12/2014 5:20:00 PM - Zacks.com

Regeneron Misses on Earnings in Q2, Eylea Drives Sales Beat - Analyst Blog
8/5/2014 3:02:00 PM - Zacks.com

EUROPE MARKETS: Germany's DAX Posts Biggest Weekly Loss In Two Years
8/1/2014 11:53:00 AM - Dow Jones Business News

Bayer Earnings Grow Marginally Y/Y, New Products Encourage - Analyst Blog
7/31/2014 10:41:00 AM - Zacks.com

Regeneron's Eylea Gets FDA Nod for Diabetic Macular Edema - Analyst Blog
7/30/2014 7:00:00 PM - Zacks.com

Bayer Q2 Profit Rises 13%
7/30/2014 4:07:00 AM - RTT News

FDA Approves Bayer's Eylea for Diabetic Macular Edema Treatment
7/30/2014 3:50:00 AM - Dow Jones Business News

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog
7/29/2014 12:30:00 PM - Zacks.com

Merck Q2 Results Beat Estimates, Lifts FY14 Earnings View
7/29/2014 8:36:00 AM - RTT News

Bayer/Amgen's Nexavar Does Not Show Resilience in Study - Analyst Blog
7/25/2014 2:45:00 PM - Zacks.com

Bayer and Onyx Say Phase III Trial of Nexavar Breast Cancer Treatment Failed
7/25/2014 3:21:00 AM - Dow Jones Business News

Bayer, Onyx Pharma Say Phase 3 Trial Of NEXAVAR Fails To Meet Primary Endpoint
7/25/2014 2:44:00 AM - RTT News

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog
7/22/2014 5:20:00 PM - Zacks.com

Regeneron Shares Jump as Sanofi Increases Stake - Analyst Blog
7/2/2014 11:30:00 AM - Zacks.com

Bayer Drugs Get Positive CHMP Recommendation - Analyst Blog
6/30/2014 4:20:00 PM - Zacks.com

Bayer Inks Hemophilia Deal with Dimension Therapeutics - Analyst Blog
6/25/2014 4:45:00 PM - Zacks.com

Vertex Pharma Skyrockets on Cystic Fibrosis Drug Trial Results - Analyst Blog
6/25/2014 10:45:00 AM - Zacks.com

Abbott Labs to Buy Russia-Based Veropharm - Analyst Blog
6/24/2014 4:15:00 PM - Zacks.com

Bayer, Dimension Therapeutics to Develop Gene Therapy for Hemophilia
6/23/2014 6:48:00 AM - Dow Jones Business News

OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog
6/20/2014 3:50:00 PM - Zacks.com

Merck Begins Tender Offer To Acquire Idenix - Update
6/20/2014 9:03:00 AM - RTT News